Covishield (COVID-19 coronavirus vaccine)

2021: Death of 180 vaccinated in India

As of the end of March 2021 India , 180 cases (29.2%) of patients died after vaccination with Covishield from, as COVID-19 well. medicine of AstraZeneca A total of 617 cases of different severity of adverse reactions were recorded. This was reported by the National Committee for Adverse Effects after Immunization (AEFI).

According to the vaccination report, there were 180 deaths in India, 305 cases of serious adverse reactions requiring hospitalization and 63 cases requiring no hospitalization. More than 63 deaths (almost 51%) were classified as caused by acute coronary syndrome (a number of conditions associated with a sudden decrease in blood flow to the heart) or a heart attack. Another 11 deaths (12%) are related to stroke.

In India, 180 vaccinated Covishield and the drug died from COVID-19 AstraZeneca

Within the first week after vaccination, 59 people died due to acute coronary syndrome or heart attack, but only four people within two to four weeks after vaccination. 13 stroke deaths were recorded in the first week after vaccination, but only one death two to four weeks after vaccination. Within the first week of administration of the COVID-19 drug, nine "sudden deaths" occurred, and only one death within two to four weeks of administration of Covishield.

The researchers noted the presence of weakness in one, two or all four limbs in 17 hospitalized patients - symptoms similar to the manifestations of transverse myelitis seen in patients during the UK study. In India, about 15 cases of convulsive seizures were recorded in the first week after the introduction of Covishield and no such case within two to four weeks after vaccination is normal.

Something's going on in the central nervous system. In addition, 17 cases of mono/para/quadriparesis in four weeks require a thorough investigation, experts say.[1]

Notes